← FDA Drug Approvals (Drugs@FDA)

ZERIT XR

NDA · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2002-12-31

Drug application

FDA Application #

NDA021453

Application type

New Drug Application

Brand name

ZERIT XR

Generic name

Stavudine

Active ingredients

STAVUDINE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

BRISTOL MYERS SQUIBB

First approval

2002-12-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown